GlobalData

The industry reported 131 Venture Capital (VC) deals worth $4.4 billion in January 2022, compared to the last 12-month average…

The industry reported 117 venture capital (VC) deals worth $3.8 billion in December 2021, compared to the last 12-month average of…

The company noted that despite this surprisingly low number and the clear need for new therapies, the late-stage pipeline is…

Zydus Cadila has recently filed desidustat in India based on Dream-ND (588 patients) and Dream-D (392 patients) phase-III trials'…

GlobalData’s report states that PE-backed CMOs will find they have a lot more financial support to add to their service offerings…

The COVID-19 pandemic has given businesses an unprecedented opportunity to implement technology-fueled changes to the way they…

COVID-19 vaccines based on mRNA technology dominate the 7MM in 2021 with a market share of 95.4 per cent and $9.5 billion in sales…

The four molecules expected to launch first, autogene cevumeran, GRANITE-001, ATL001, and Genocea Biosciences’ GEN-009 have…

Out of the 23 drugs in the pipeline, 13 are being investigated for GI indications, with the majority targeting ulcerative colitis…

Growth will be driven by recent drug launches